BA
WST icon

Bridgewater Associates’s West Pharmaceutical WST Stock Holding History

Bridgewater Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74M Sell
10,429
-12,732
-55% -$3.89M 0.02% 537
2026
Q1 		$5.81M Buy
23,161
+19,088
+469% +$4.75M 0.03% 389
2025
Q4 		$1.12M Buy
+4,073
New +$1.11M ﹤0.01% 867
2024
Q2 		– Sell
-1,292
Closed -$511K – 945
2024
Q1 		$511K Sell
1,292
-3,101
-71% -$1.15M ﹤0.01% 621
2023
Q4 		$1.55M Sell
4,393
-262
-6% -$92.7K 0.01% 568
2023
Q3 		$1.75M Sell
4,655
-280
-6% -$108K 0.01% 517
2023
Q2 		$1.89M Sell
4,935
-30
-0.6% -$10.7K 0.01% 469
2023
Q1 		$1.72M Sell
4,965
-7,254
-59% -$2.12M 0.01% 485
2022
Q4 		$2.88M Sell
12,219
-29,858
-71% -$7.08M 0.02% 466
2022
Q3 		$10.4M Buy
42,077
+18,921
+82% +$5.76M 0.05% 248
2022
Q2 		$7M Buy
23,156
+12,266
+113% +$3.99M 0.03% 411
2022
Q1 		$4.47M Buy
10,890
+2,525
+30% +$988K 0.02% 496
2021
Q4 		$3.92M Sell
8,365
-75,708
-90% -$32.6M 0.02% 349
2021
Q3 		$35.7M Sell
84,073
-3,495
-4% -$1.47M 0.2% 96
2021
Q2 		$31.4M Buy
87,568
+39,073
+81% +$12.9M 0.2% 90
2021
Q1 		$13.7M Buy
48,495
+6,132
+14% +$1.75M 0.12% 132
2020
Q4 		$12M Buy
42,363
+24,718
+140% +$6.94M 0.1% 108
2020
Q3 		$4.85M Buy
+17,645
New +$4.67M 0.06% 142

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bridgewater Associates's WST Position: Q2 2026 in Review

Bridgewater Associates reduced its West Pharmaceutical (WST) stake by 55% in Q2 2026, selling an estimated $3.89M and leaving 10,429 shares worth $3.74M. The position accounts for 0.02% of the portfolio, ranked #537.

Bridgewater Associates first reported a position in WST in Q3 2020 and has held it in 18 quarters since. The position peaked at $35.7M in Q3 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bridgewater Associates held 10,429 shares of West Pharmaceutical worth $3.74M as of Q2 2026.
  • Bridgewater Associates sold 12,732 West Pharmaceutical shares in Q2 2026, an estimated $3.89M.
  • West Pharmaceutical made up 0.02% of Bridgewater Associates's portfolio in Q2 2026, its #537 holding.
  • Bridgewater Associates first reported a position in West Pharmaceutical in Q3 2020 and has held it in 18 quarters since.
  • Bridgewater Associates's West Pharmaceutical position peaked at $35.7M in Q3 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.